Ind-Swift Laboratories Ltd.
Snapshot View

64.35 -2.25 ▼-3.4%

27 January 2023, 04:01:00 PM
Volume: 6,610

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.indswiftlabs.com
Market Cap 380.52 Cr.
Enterprise Value(EV) 1,295.93 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -0.03 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 75.99 Trailing Twelve Months Ending 2022-09
Price to Book Value 0.85 Calculated using Price: 64.35
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 5.91 Cr. 59,086,860 Shares
FaceValue 10
Company Profile
Ind-Swift Laboratories is a part of the Ind-swift Group and is based at Chandigarh, India. It has been promoted by Ind-Swift Limited in a joint venture with the Punjab State Industrial Development Corporation Limited (PSIDC). The group has established a strong reputation as innovators in the Indian pharmaceutical industry.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.38%
1 Week
-3.09%
1 Month
-2.94%
3 Month
+19.28%
6 Month
+9.72%
1 Year
-14.14%
2 Year
-6.13%
5 Year
+4.13%
10 Year
+33.78%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -27.88 -36.36 -23.11 -15.89 7.89 8.99 -5.56 -0.78 -0.54
Return on Capital Employed (%) -1.46 -1.52 1.40 2.19 4.59 9.25 5.97 8.31 7.85
Return on Assets (%) -5.18 -5.22 -2.65 -1.86 1.11 1.53 -1.17 -0.18 -0.12

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 725 595 517 531 553 588 641 604 601 646
Non Curr. Liab. 983 811 717 495 438 901 828 840 814 777
Curr. Liab. 630 833 951 1,005 936 356 323 315 335 342
Minority Int. 0 0 0
Equity & Liab. 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,766
Non Curr. Assets 1,350 1,319 1,264 1,202 1,088 1,009 929 814 673 648
Curr. Assets 989 920 922 829 839 836 863 942 1,074 1,117
Misc. Exp. not W/O
Total Assets 2,339 2,239 2,185 2,031 1,927 1,845 1,792 1,758 1,749 1,766

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 965 660 653 697 763 757 780 891 1,039 1,144
Other Income 14 22 16 23 26 37 33 23 43 45
Total Income 979 683 669 720 788 794 813 914 1,082 1,188
Total Expenditure -906 -572 -546 -591 -628 -630 -636 -709 -843 -943
PBIDT 73 111 123 129 160 163 177 206 239 245
Interest -117 -117 -106 -90 -35 -92 -107 -100 -96 -95
Depreciation -66 -84 -85 -88 -87 -104 -90 -87 -131 -136
Taxation 20 24 24 16 -14 -21 -1 -21 -15 -15
Exceptional Items -33 -53 -15 -5 -2 83
PAT -122 -119 -59 -39 22 29 -21 -3 -2 0
Minority Interest
Share Associate 0
Other Related Items
Consolidated Net Profit -122 -119 -59 -39 22 29 -21 -3 -2 0
Adjusted EPS -30 -29 -14 -9 5 6 -4 -1 0 0

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -47 66 98 79 96 73 -64 125 135 150
Cash Fr. Inv. -48 -27 -36 -30 -31 -17 -12 -9 -10 5
Cash Fr. Finan. 66 -38 -64 -48 -69 -62 100 -133 -124 -141
Net Change -29 0 -1 2 -4 -6 23 -17 1 14
Cash & Cash Eqvt 18 21 20 22 16 9 30 11 12 26

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00 42.00
Public 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00 58.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 86.87 86.87 86.87 86.87 86.87 86.81 86.84 86.84 86.84

Announcements View Details >>

Sat, 28 Jan 2023
Board Meeting Intimation for Consideration And Approval Of Un-Audited Financial Results For Quarter And Nine Months Ended 31St December 2022.
IND-SWIFT LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve Un-Audited Financial Results For Quarter And Nine Months Ended 31st December 2022.
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022.
Wed, 04 Jan 2023
Compliance-57 (5) : intimation after the end of quarter
Intimation under Regulation 57(5) of SEBI (LODR) Regulations 2015

Technical Scans View Details >>

Fri, 27 Jan 2023
Closing Below Previous Low Closing Below Previous Low
High Increase in 3 Months High Increase in 3 Months
Close Crossing 50 SMA From Above Close Crossing 50 SMA From Above
CCI Crossed Below -100 CCI Crossed Below -100
RSI Trending Down RSI Trending Down

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On Ind-Swift Laboratories Ltd.

What is Ind-Swift Lab. share price?

Can I buy Ind-Swift Lab. shares now?

What is the Market Cap of Ind-Swift Lab.?

What are the key metrics to analyse Ind-Swift Lab.?

What is the 52 Week High and Low of Ind-Swift Lab.?

What is the trend of Ind-Swift Lab. share price?